Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes.
Open Access
- 1 October 1994
- journal article
- research article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 269 (41), 25735-25741
- https://doi.org/10.1016/s0021-9258(18)47309-7
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Disruption of PDGF Receptor Trafficking by Mutation of Its PI-3 Linase Binding SitesScience, 1994
- Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus.JCI Insight, 1993
- Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats.JCI Insight, 1993
- Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice.JCI Insight, 1993
- Activation by Protein Synthesis Inhibitors of Glucose Transport into L6 Muscle CellsBiochemical and Biophysical Research Communications, 1993
- New Pharmacological Approaches to Therapy of NIDDMDiabetes Care, 1992
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992
- Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucoseCell, 1986
- Muscle proteins related to microtubule associated protein-2 are substrates for an insulin-stimulatable kinaseBiochemical and Biophysical Research Communications, 1986
- Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformationNature, 1985